MedPath

Study to rationalize antibiotic usage in NIC

Not Applicable
Conditions
Health Condition 1: P369- Bacterial sepsis of newborn, unspecifiedHealth Condition 2: P399- Infection specific to the perinatal period, unspecified
Registration Number
CTRI/2021/05/033353
Lead Sponsor
KASTURBA MEDICAL COLLEGE MANIPA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

all babies on antibiotics( both preterm and term)

Exclusion Criteria

nil

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to optimise the use of antimicrobials in NICUTimepoint: at end of 6 month and 9 month
Secondary Outcome Measures
NameTimeMethod
Establishment of antimicrobial use protocol <br/ ><br> <br/ ><br>Timepoint: End of 6 months
© Copyright 2025. All Rights Reserved by MedPath